Genomics at Scale: Bridging UK Innovation, Healthcare, and Life Sciences
This article is a sponsored feature, produced in partnership with Genomics ltd. In this conversation, Professor Sir Peter Donnelly explains how Genomics is turning cutting-edge
This article is a sponsored feature, produced in partnership with Genomics ltd. In this conversation, Professor Sir Peter Donnelly explains how Genomics is turning cutting-edge
The UK Covid Inquiry’s conclusion that the NHS “came close to collapse” exposes deep structural weaknesses in the health system and raises urgent questions about preparedness, capacity, and political accountability.
At Curia’s NHS innovation summit in Barnsley, South Yorkshire Mayor, Oliver Coppard argues regional leaders – not Whitehall – hold the key to unlocking health-driven economic growth.
From AI and quantum computing to advanced healthcare imaging, the UK’s ability to lead in the technologies of the future may depend on a single, often overlooked field: photonics.
As the CMA launches an investigation into the private dentistry market and new data reveals £900m in unfulfilled NHS dental contracts, ministers and NHS leaders set out what comes next for the future of dental care in England.
There is no excerpt because this is a protected post.
As the Health Innovation Minister calls Genomics a “jewel in our crown”, Britain’s AI-powered drug discovery revolution accelerates from the heart of King’s Cross.
According to the new interim report of the Maternity Review, England’s maternity services are failing too many families – and without structural reform, workforce investment and decisive action on toxic culture and racism, the system risks repeating the same tragedies it has already documented.
As UK Healthcare and Life Sciences Innovation (UKHLSI) launches, newly appointed Chief Executive, Joanne Bekis writes the UK leads the world in healthcare and life sciences research – but until we fix how innovation is adopted, scaled and sustained across the NHS, patients and the economy will never experience the full benefit.
A manufacturing failure affecting the majority supplier of surgical bone cement could delay thousands of hip and knee operations – exposing fresh fragilities in NHS elective recovery plans.
A new £20 million government funding round aims to fast-track breakthrough medicines, artificial intelligence and digital technologies into frontline addiction services – with ministers signalling a clear push to turn UK science into life-saving impact.
Why governing artificial intelligence in the NHS is less about new rules and more about using the ones we already have properly.
Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.